Clinical and endocrine response to the withdrawal of gonadotropin-releasing hormone agonists during prolonged coasting

Fertility and Sterility

Volumn 92, Issue 2, 2009, Pages 499-507

  Ho Yuen, Basil ^a   Nguyen, Tuan Anh T ^a   Cheung, Anthony P ^a   Leung, Peter C K ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

coasting; ICSI; IVF; ovarian hyperstimulation syndrome; Withdrawing GnRH agonists

Indexed keywords

ANDROSTENEDIONE; BUSERELIN; BUSERELIN ACETATE; CHORIONIC GONADOTROPIN; ESTRADIOL; FOLLITROPIN; LUTEINIZING HORMONE; MUELLERIAN INHIBITING FACTOR; NAFARELIN ACETATE; PROGESTERONE; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; UROFOLLITROPIN;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FOLLITROPIN BLOOD LEVEL; HORMONE RESPONSE; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; LUTEINIZING HORMONE BLOOD LEVEL; OOCYTE RETRIEVAL; OVARY HYPERSTIMULATION; PREGNANCY RATE; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RETROSPECTIVE STUDY; TREATMENT RESPONSE;

ADULT; DINOPROSTONE; DRUG ADMINISTRATION SCHEDULE; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY, FEMALE; OVULATION INDUCTION; PREGNANCY; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 67651096041     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2008.06.039     Document Type: Article

References (32)

1. Rabinovici J., Kushnir O., Shalev J., Goldenberg M., and Blankstein J. Rescue of menotrophin cycles prone to develop ovarian hyperstimulation. Br J Obstet Gynecol 94 (1987) 1098-1102
2. Urman B., Pride S.M., and Ho Yuen B. Management of overstimulated gonadotrophin cycles with a controlled drift. Hum Reprod 7 (1992) 213-217
3. Sher G., Salem R., Feinman M., Dodge S., Zouves C., and Knutzen V. Eliminating the risk of life-endangering complications following overstimulation with menotropin fertility agents: a report on women undergoing in vitro fertilization and embryo transfer. Obstet Gynecol 81 (1993) 1009-1011
4. Rizk B.R.M.B. Ovarian hyperstimulation syndrome (2006), Cambridge University Press, Cambridge
5. Egbase P.E., Al Sharban M., Berlingieri P., and Grudzinskas J.G. Serum oestradiol and progesterone concentrations during prolonged coasting in 15 women at risk of ovarian hyperstimulation syndrome following ovarian stimulation for assisted reproduction treatment. Hum Reprod 15 (2000) 2082-2086
6. Garcia-Velasco J.A., Isaza V., Quea G., and Pellicer A. Coasting for the prevention of ovarian hyperstimulation syndrome: much ado about nothing. Fertil Steril 85 (2006) 547-554
7. Hsueh A.J.W., and Jones P.B.C. Extrapituitary actions of gonodotropin-releasing hormone. Endocr Rev 2 (1981) 437-461
8. Cheng C.K., and Leung P.C.K. Molecular biology of gonadotropin releasing hormone (GnRH)-I, GnRH-II, and their receptors in humans. Endocr Rev 26 (2005) 283-306
9. Sheena Rani C.S., Ekholm C., Billig H., Magnusson C., and Hillensjo T. Biphasic effect of gonadotropin-releasing hormone on progestin secretion by rat granulosa cells. Biol Reprod 28 (1983) 591-597
10. Ranta T., Knecht M., Baukal A.J., Korhonen M., and Catt K.J. GnRH agonist-induced inhibitory and stimulatory effects during ovarian follicular maturation. Mol Cell Endocrinol 35 (1984) 55-63
11. Ranta T., Knecht M., Kody M., and Catt K.J. GnRH receptors in cultured rat granulosa cells: mediation of the inhibitory and stimulatory actions of GnRH. Mol Cell Endocrinol 27 (1982) 233-240
12. Noar Z., Zilberstein M., Zakut H., Lindner H.R., and Dekel N. Dissociation between the direct stimulatory and inhibitory effects of a gonadotropin-releasing hormone analog on ovarian functions. Mol Cell Endocrinol 31 (1983) 261-270
13. Maruo T., Otani T., and Mochizuki M. Antigonadotropic actions of GnRH agonist on ovarian cells in vivo and in vitro. J Steroid Biochem 23 (1985) 765-770
14. Navot D., Bergh P.A., and Laufer N. Ovarian hyperstimulation syndrome in novel reproductive technologies: prevention and treatment. Fertil Steril 58 (1992) 249-261
15. Benadiva C.A., Davis O., Kligman I., Moomjy M., Liu H.-C., and Rosenswaks Z. Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil Steril 67 (1997) 724-727
16. Seifer D.B., and MacLauglin D.T. Mullerian inhibiting substance is an ovarian growth factor of emerging significance. Fertil Steril 88 (2007) 539-546
17. Visser J.A., de Jong F.H., Laven J.S.E., and Themmen A.P.N. Anti-mullerian hormone: a new marker for ovarian function. Reproduction 131 (2006) 1-9
18. Lee T.-H., Liu C.-H., Huang C.-C., Wu Y.-L., Shih Y.-T., Ho H.-N., et al. Serum anti-mullerian hormone and estradiol levels as predictors of ovarian hyperstimulation syndrome in assisted reproductive technology cycles. Hum Reprod 23 (2008) 160-167
19. La Marca A., Giulini S., Tirelli A., Bertucci E., Marsella T., Xella S., et al. Anti-mullerian hormone measurement on any day of the menstrual cycle strongly predicts ovarian response in assisted reproductive technology. Hum Reprod 22 (2007) 766-771
20. Choi J.-H., Gilks C.B., Auersperg N., and Leung P.C.K. Immunolocalization of gonadotropin-releasing hormone (GnRH)-I, GnRH-II, and type I GnRH receptor during follicular development in the human ovary. J Clin Endocrinol Metab 91 (2006) 4562-4570
21. Clark M.R., Thibier C., Marsh J.M., and LeMaire W.J. Stimulation of prostaglandin accumulation by luteinizing hormone-releasing hormone (LHRH) and LHRH analogs in rat granulosa cells in vitro. Endocrinology 107 (1980) 17-23
22. Hillensjo T., LeMaire W.J., Clark M.R., and Ahren K. Effect of gonadotrophin-releasing hormone (GnRH) and GnRH agonists upon accumulation of progesterone, cAMP and prostaglandin in isolated preovulatory rat follicles. Acta Endocrinol (Copenh) 101 (1982) 603-610
23. Parinaud J., Oustry P., Bussenot I., Tourre A., Perinau M., Plantavid M., et al. Paradoxical ovarian stimulations in the use of LHRH analogs. Eur J Obstet Gynecol and Reprod Biol 47 (1992) 129-133
24. Parinaud J., Beaur A., Bourreau E., Vieitez G., and Pontonnier G. Effect of a luteinizing hormone-releasing hormone agonist (Buserelin) on steroidogenesis of cultured human preovulatory granulosa cells. Fertil Steril 50 (1985) 597-602
25. Bussenot I., Azoulay-Barjonet C., and Parinaud J. Modulation of the steroidogenesis of cultured human granulosa-lutein cells by gonadotropin-releasing hormone analogs. J Clin Endocrinol Metab 76 (1993) 1376-1379
26. Hampton H.L., Whitworth N.S., and Cowan B.D. Gonadotropin-releasing hormone agonist (leuprolide acetate) induced hyperstimulation syndrome in a woman undergoing intermittent hemodialysis. Fertil Steril 55 (1991) 429-431
27. Droesch K., and Barbieri R.L. Ovarian hyperstimulation syndrome associated with the use of gonadotropin-releasing hormone agonist leuprolide acetate. Fertil Steril 62 (1994) 189-190
28. Brett S., Yong P.Y.K., and Thong K.J. Ovarian hyperstimulation after the sole use of a gonadotrophin-releasing hormone agonist (Naferelin) as a complication of in vitro fertilisation treatment. J Assist Reprod Genet 18 (2001) 353-356
29. Weissman A., Barash A., Shapiro H., and Casper R. Ovarian hyperstimulation following the sole administration of agonistic analogues of gonadotrophin releasing hormone. Hum Reprod 13 (1998) 3421-3424
30. Mehta R.H., and Anand Kumar T.C. Can GnRH agonists act directly on the ovary and contribute to cyst formation?. Hum Reprod 15 (1999) 505-507
31. Lui Y.-X., Hu Z.-Y., Feng Q., and Zou R.-J. Paradoxical effect of a GnRH agonist on steroidogenesis in cultured monkey granulosa cells. Science in China (Series B) 34 (1991) 1452-1460
32. Loumaye E., Coen G., Pampfer S., Vankrieken L., and Thomas K. Use of a gonadotropin-releasing hormone agonist during ovarian stimulation leads to significant concentrations of peptide in follicular fluids. Fertil Steril 52 (1989) 256-263